Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma

NCT01011439 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
72
Enrollment
INDUSTRY
Sponsor class

Stopped For the 2 last patients still on treated nominal therapeutic use of the Milciclib was approved at INT Milano.

Conditions

Interventions

Sponsor

Tiziana Life Sciences LTD